Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Viscosupplementation for Knee Osteoarthritis Market Growth 2022-2028

  • LP 4802689
  • 98 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Viscosupplementation for Knee Osteoarthritis will have significant change from previous year. According to our (LP Information) latest study, the global Viscosupplementation for Knee Osteoarthritis market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Viscosupplementation for Knee Osteoarthritis market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Viscosupplementation for Knee Osteoarthritis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Viscosupplementation for Knee Osteoarthritis market, reaching US$ million by the year 2028. As for the Europe Viscosupplementation for Knee Osteoarthritis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Viscosupplementation for Knee Osteoarthritis players cover Sanofi, Anika Therapeutics, Seikagaku, and Zimmer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Viscosupplementation for Knee Osteoarthritis market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Single Injection

Three Injection

Five Injection

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals

Clinics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Sanofi

Anika Therapeutics

Seikagaku

Zimmer

Bioventus

Ferring

Lifecore Biomedical

LG Life Sciences

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Viscosupplementation for Knee Osteoarthritis Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Viscosupplementation for Knee Osteoarthritis by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Viscosupplementation for Knee Osteoarthritis by Country/Region, 2017, 2022 & 2028

2.2 Viscosupplementation for Knee Osteoarthritis Segment by Type

2.2.1 Single Injection

2.2.2 Three Injection

2.2.3 Five Injection

2.3 Viscosupplementation for Knee Osteoarthritis Sales by Type

2.3.1 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2022)

2.3.2 Global Viscosupplementation for Knee Osteoarthritis Revenue and Market Share by Type (2017-2022)

2.3.3 Global Viscosupplementation for Knee Osteoarthritis Sale Price by Type (2017-2022)

2.4 Viscosupplementation for Knee Osteoarthritis Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Viscosupplementation for Knee Osteoarthritis Sales by Application

2.5.1 Global Viscosupplementation for Knee Osteoarthritis Sale Market Share by Application (2017-2022)

2.5.2 Global Viscosupplementation for Knee Osteoarthritis Revenue and Market Share by Application (2017-2022)

2.5.3 Global Viscosupplementation for Knee Osteoarthritis Sale Price by Application (2017-2022)

3 Global Viscosupplementation for Knee Osteoarthritis by Company

3.1 Global Viscosupplementation for Knee Osteoarthritis Breakdown Data by Company

3.1.1 Global Viscosupplementation for Knee Osteoarthritis Annual Sales by Company (2020-2022)

3.1.2 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2020-2022)

3.2 Global Viscosupplementation for Knee Osteoarthritis Annual Revenue by Company (2020-2022)

3.2.1 Global Viscosupplementation for Knee Osteoarthritis Revenue by Company (2020-2022)

3.2.2 Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Company (2020-2022)

3.3 Global Viscosupplementation for Knee Osteoarthritis Sale Price by Company

3.4 Key Manufacturers Viscosupplementation for Knee Osteoarthritis Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Viscosupplementation for Knee Osteoarthritis Product Location Distribution

3.4.2 Players Viscosupplementation for Knee Osteoarthritis Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Viscosupplementation for Knee Osteoarthritis by Geographic Region

4.1 World Historic Viscosupplementation for Knee Osteoarthritis Market Size by Geographic Region (2017-2022)

4.1.1 Global Viscosupplementation for Knee Osteoarthritis Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Viscosupplementation for Knee Osteoarthritis Annual Revenue by Geographic Region

4.2 World Historic Viscosupplementation for Knee Osteoarthritis Market Size by Country/Region (2017-2022)

4.2.1 Global Viscosupplementation for Knee Osteoarthritis Annual Sales by Country/Region (2017-2022)

4.2.2 Global Viscosupplementation for Knee Osteoarthritis Annual Revenue by Country/Region

4.3 Americas Viscosupplementation for Knee Osteoarthritis Sales Growth

4.4 APAC Viscosupplementation for Knee Osteoarthritis Sales Growth

4.5 Europe Viscosupplementation for Knee Osteoarthritis Sales Growth

4.6 Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales Growth

5 Americas

5.1 Americas Viscosupplementation for Knee Osteoarthritis Sales by Country

5.1.1 Americas Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2022)

5.1.2 Americas Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2022)

5.2 Americas Viscosupplementation for Knee Osteoarthritis Sales by Type

5.3 Americas Viscosupplementation for Knee Osteoarthritis Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Viscosupplementation for Knee Osteoarthritis Sales by Region

6.1.1 APAC Viscosupplementation for Knee Osteoarthritis Sales by Region (2017-2022)

6.1.2 APAC Viscosupplementation for Knee Osteoarthritis Revenue by Region (2017-2022)

6.2 APAC Viscosupplementation for Knee Osteoarthritis Sales by Type

6.3 APAC Viscosupplementation for Knee Osteoarthritis Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Viscosupplementation for Knee Osteoarthritis by Country

7.1.1 Europe Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2022)

7.1.2 Europe Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2022)

7.2 Europe Viscosupplementation for Knee Osteoarthritis Sales by Type

7.3 Europe Viscosupplementation for Knee Osteoarthritis Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Viscosupplementation for Knee Osteoarthritis by Country

8.1.1 Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2022)

8.1.2 Middle East & Africa Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2022)

8.2 Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales by Type

8.3 Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Viscosupplementation for Knee Osteoarthritis

10.3 Manufacturing Process Analysis of Viscosupplementation for Knee Osteoarthritis

10.4 Industry Chain Structure of Viscosupplementation for Knee Osteoarthritis

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Viscosupplementation for Knee Osteoarthritis Distributors

11.3 Viscosupplementation for Knee Osteoarthritis Customer

12 World Forecast Review for Viscosupplementation for Knee Osteoarthritis by Geographic Region

12.1 Global Viscosupplementation for Knee Osteoarthritis Market Size Forecast by Region

12.1.1 Global Viscosupplementation for Knee Osteoarthritis Forecast by Region (2023-2028)

12.1.2 Global Viscosupplementation for Knee Osteoarthritis Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Viscosupplementation for Knee Osteoarthritis Forecast by Type

12.7 Global Viscosupplementation for Knee Osteoarthritis Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Viscosupplementation for Knee Osteoarthritis Product Offered

13.1.3 Sanofi Viscosupplementation for Knee Osteoarthritis Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 Anika Therapeutics

13.2.1 Anika Therapeutics Company Information

13.2.2 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Product Offered

13.2.3 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Anika Therapeutics Main Business Overview

13.2.5 Anika Therapeutics Latest Developments

13.3 Seikagaku

13.3.1 Seikagaku Company Information

13.3.2 Seikagaku Viscosupplementation for Knee Osteoarthritis Product Offered

13.3.3 Seikagaku Viscosupplementation for Knee Osteoarthritis Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Seikagaku Main Business Overview

13.3.5 Seikagaku Latest Developments

13.4 Zimmer

13.4.1 Zimmer Company Information

13.4.2 Zimmer Viscosupplementation for Knee Osteoarthritis Product Offered

13.4.3 Zimmer Viscosupplementation for Knee Osteoarthritis Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Zimmer Main Business Overview

13.4.5 Zimmer Latest Developments

13.5 Bioventus

13.5.1 Bioventus Company Information

13.5.2 Bioventus Viscosupplementation for Knee Osteoarthritis Product Offered

13.5.3 Bioventus Viscosupplementation for Knee Osteoarthritis Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bioventus Main Business Overview

13.5.5 Bioventus Latest Developments

13.6 Ferring

13.6.1 Ferring Company Information

13.6.2 Ferring Viscosupplementation for Knee Osteoarthritis Product Offered

13.6.3 Ferring Viscosupplementation for Knee Osteoarthritis Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Ferring Main Business Overview

13.6.5 Ferring Latest Developments

13.7 Lifecore Biomedical

13.7.1 Lifecore Biomedical Company Information

13.7.2 Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Product Offered

13.7.3 Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Lifecore Biomedical Main Business Overview

13.7.5 Lifecore Biomedical Latest Developments

13.8 LG Life Sciences

13.8.1 LG Life Sciences Company Information

13.8.2 LG Life Sciences Viscosupplementation for Knee Osteoarthritis Product Offered

13.8.3 LG Life Sciences Viscosupplementation for Knee Osteoarthritis Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 LG Life Sciences Main Business Overview

13.8.5 LG Life Sciences Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Viscosupplementation for Knee Osteoarthritis Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Viscosupplementation for Knee Osteoarthritis Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Single Injection

Table 4. Major Players of Three Injection

Table 5. Major Players of Five Injection

Table 6. Global Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)

Table 7. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2022)

Table 8. Global Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2022) & ($ million)

Table 9. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2017-2022)

Table 10. Global Viscosupplementation for Knee Osteoarthritis Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)

Table 12. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2022)

Table 13. Global Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2022)

Table 14. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application (2017-2022)

Table 15. Global Viscosupplementation for Knee Osteoarthritis Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Viscosupplementation for Knee Osteoarthritis Sales by Company (2020-2022) & (K Units)

Table 17. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Company (2020-2022)

Table 18. Global Viscosupplementation for Knee Osteoarthritis Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Company (2020-2022)

Table 20. Global Viscosupplementation for Knee Osteoarthritis Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Viscosupplementation for Knee Osteoarthritis Producing Area Distribution and Sales Area

Table 22. Players Viscosupplementation for Knee Osteoarthritis Products Offered

Table 23. Viscosupplementation for Knee Osteoarthritis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Viscosupplementation for Knee Osteoarthritis Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share Geographic Region (2017-2022)

Table 28. Global Viscosupplementation for Knee Osteoarthritis Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Viscosupplementation for Knee Osteoarthritis Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Country/Region (2017-2022)

Table 32. Global Viscosupplementation for Knee Osteoarthritis Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2022) & (K Units)

Table 35. Americas Viscosupplementation for Knee Osteoarthritis Sales Market Share by Country (2017-2022)

Table 36. Americas Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Country (2017-2022)

Table 38. Americas Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)

Table 39. Americas Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2022)

Table 40. Americas Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)

Table 41. Americas Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2022)

Table 42. APAC Viscosupplementation for Knee Osteoarthritis Sales by Region (2017-2022) & (K Units)

Table 43. APAC Viscosupplementation for Knee Osteoarthritis Sales Market Share by Region (2017-2022)

Table 44. APAC Viscosupplementation for Knee Osteoarthritis Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Region (2017-2022)

Table 46. APAC Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)

Table 47. APAC Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2022)

Table 48. APAC Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)

Table 49. APAC Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2022)

Table 50. Europe Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2022) & (K Units)

Table 51. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Country (2017-2022)

Table 52. Europe Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Country (2017-2022)

Table 54. Europe Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)

Table 55. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2022)

Table 56. Europe Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)

Table 57. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Viscosupplementation for Knee Osteoarthritis

Table 67. Key Market Challenges & Risks of Viscosupplementation for Knee Osteoarthritis

Table 68. Key Industry Trends of Viscosupplementation for Knee Osteoarthritis

Table 69. Viscosupplementation for Knee Osteoarthritis Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Viscosupplementation for Knee Osteoarthritis Distributors List

Table 72. Viscosupplementation for Knee Osteoarthritis Customer List

Table 73. Global Viscosupplementation for Knee Osteoarthritis Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Viscosupplementation for Knee Osteoarthritis Sales Market Forecast by Region

Table 75. Global Viscosupplementation for Knee Osteoarthritis Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Viscosupplementation for Knee Osteoarthritis Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Viscosupplementation for Knee Osteoarthritis Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Viscosupplementation for Knee Osteoarthritis Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Viscosupplementation for Knee Osteoarthritis Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Viscosupplementation for Knee Osteoarthritis Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Viscosupplementation for Knee Osteoarthritis Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Viscosupplementation for Knee Osteoarthritis Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Viscosupplementation for Knee Osteoarthritis Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Viscosupplementation for Knee Osteoarthritis Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Viscosupplementation for Knee Osteoarthritis Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share Forecast by Application (2023-2028)

Table 93. Sanofi Basic Information, Viscosupplementation for Knee Osteoarthritis Manufacturing Base, Sales Area and Its Competitors

Table 94. Sanofi Viscosupplementation for Knee Osteoarthritis Product Offered

Table 95. Sanofi Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Sanofi Main Business

Table 97. Sanofi Latest Developments

Table 98. Anika Therapeutics Basic Information, Viscosupplementation for Knee Osteoarthritis Manufacturing Base, Sales Area and Its Competitors

Table 99. Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Product Offered

Table 100. Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Anika Therapeutics Main Business

Table 102. Anika Therapeutics Latest Developments

Table 103. Seikagaku Basic Information, Viscosupplementation for Knee Osteoarthritis Manufacturing Base, Sales Area and Its Competitors

Table 104. Seikagaku Viscosupplementation for Knee Osteoarthritis Product Offered

Table 105. Seikagaku Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Seikagaku Main Business

Table 107. Seikagaku Latest Developments

Table 108. Zimmer Basic Information, Viscosupplementation for Knee Osteoarthritis Manufacturing Base, Sales Area and Its Competitors

Table 109. Zimmer Viscosupplementation for Knee Osteoarthritis Product Offered

Table 110. Zimmer Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Zimmer Main Business

Table 112. Zimmer Latest Developments

Table 113. Bioventus Basic Information, Viscosupplementation for Knee Osteoarthritis Manufacturing Base, Sales Area and Its Competitors

Table 114. Bioventus Viscosupplementation for Knee Osteoarthritis Product Offered

Table 115. Bioventus Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Bioventus Main Business

Table 117. Bioventus Latest Developments

Table 118. Ferring Basic Information, Viscosupplementation for Knee Osteoarthritis Manufacturing Base, Sales Area and Its Competitors

Table 119. Ferring Viscosupplementation for Knee Osteoarthritis Product Offered

Table 120. Ferring Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Ferring Main Business

Table 122. Ferring Latest Developments

Table 123. Lifecore Biomedical Basic Information, Viscosupplementation for Knee Osteoarthritis Manufacturing Base, Sales Area and Its Competitors

Table 124. Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Product Offered

Table 125. Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Lifecore Biomedical Main Business

Table 127. Lifecore Biomedical Latest Developments

Table 128. LG Life Sciences Basic Information, Viscosupplementation for Knee Osteoarthritis Manufacturing Base, Sales Area and Its Competitors

Table 129. LG Life Sciences Viscosupplementation for Knee Osteoarthritis Product Offered

Table 130. LG Life Sciences Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. LG Life Sciences Main Business

Table 132. LG Life Sciences Latest Developments

List of Figures

Figure 1. Picture of Viscosupplementation for Knee Osteoarthritis

Figure 2. Viscosupplementation for Knee Osteoarthritis Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Viscosupplementation for Knee Osteoarthritis Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Viscosupplementation for Knee Osteoarthritis Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Viscosupplementation for Knee Osteoarthritis Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Single Injection

Figure 10. Product Picture of Three Injection

Figure 11. Product Picture of Five Injection

Figure 12. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type in 2021

Figure 13. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2017-2022)

Figure 14. Viscosupplementation for Knee Osteoarthritis Consumed in Hospitals

Figure 15. Global Viscosupplementation for Knee Osteoarthritis Market: Hospitals (2017-2022) & (K Units)

Figure 16. Viscosupplementation for Knee Osteoarthritis Consumed in Clinics

Figure 17. Global Viscosupplementation for Knee Osteoarthritis Market: Clinics (2017-2022) & (K Units)

Figure 18. Viscosupplementation for Knee Osteoarthritis Consumed in Others

Figure 19. Global Viscosupplementation for Knee Osteoarthritis Market: Others (2017-2022) & (K Units)

Figure 20. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2022)

Figure 21. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application in 2021

Figure 22. Viscosupplementation for Knee Osteoarthritis Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Company in 2021

Figure 24. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Geographic Region in 2021

Figure 26. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Region (2017-2022)

Figure 27. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Country/Region in 2021

Figure 28. Americas Viscosupplementation for Knee Osteoarthritis Sales 2017-2022 (K Units)

Figure 29. Americas Viscosupplementation for Knee Osteoarthritis Revenue 2017-2022 ($ Millions)

Figure 30. APAC Viscosupplementation for Knee Osteoarthritis Sales 2017-2022 (K Units)

Figure 31. APAC Viscosupplementation for Knee Osteoarthritis Revenue 2017-2022 ($ Millions)

Figure 32. Europe Viscosupplementation for Knee Osteoarthritis Sales 2017-2022 (K Units)

Figure 33. Europe Viscosupplementation for Knee Osteoarthritis Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Revenue 2017-2022 ($ Millions)

Figure 36. Americas Viscosupplementation for Knee Osteoarthritis Sales Market Share by Country in 2021

Figure 37. Americas Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Country in 2021

Figure 38. United States Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Viscosupplementation for Knee Osteoarthritis Sales Market Share by Region in 2021

Figure 43. APAC Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Regions in 2021

Figure 44. China Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Country in 2021

Figure 51. Europe Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Country in 2021

Figure 52. Germany Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Country in 2021

Figure 59. Egypt Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Viscosupplementation for Knee Osteoarthritis Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Viscosupplementation for Knee Osteoarthritis in 2021

Figure 65. Manufacturing Process Analysis of Viscosupplementation for Knee Osteoarthritis

Figure 66. Industry Chain Structure of Viscosupplementation for Knee Osteoarthritis

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390